Catecholamine treatment of ocular hypertension

Details Catecholamine treatment of ocular hypertension Catecholamine treatment of ocular hypertension

1979-03-09

1981-06-23

Robinson, Douglas W.

Drug, bio-affecting and body treating compositions

Nonspecific immunoeffector, per se ; or nonspecific...

Synthetic polymer or copolymer

424311, 424313, 424330, A61K 31365, A61K 31135, A61K 3122, A61K 31225

Patent

active

042750741

ABSTRACT:
Ocular hypertension can be treated by the topical administration of ophthalmic compositions that contain as the active ingredient an .alpha.-methyl derivative of epinephrine or norepinephrine.

REFERENCES:
patent: 3657244 (1972-04-01), Mentrup et al.
patent: 3705233 (1972-12-01), Lunts et al.
patent: 3732300 (1973-05-01), Lunts et al.
patent: 3808317 (1974-04-01), Hecht et al.
patent: 3809714 (1974-05-01), Hussain et al.
patent: 3839584 (1974-10-01), Hussain et al.
patent: 3868461 (1975-02-01), Hussain et al.
patent: 3937838 (1976-02-01), Wetlerlin et al.
Lewis's Pharmacology-Crossland-4th ed., 1970, pp. 381-382 and 386-387.

Affiliated with

Also associated with

Rating

Catecholamine treatment of ocular hypertension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Catecholamine treatment of ocular hypertension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Catecholamine treatment of ocular hypertension will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2207729